Pomalidomide Capsule
Product Images NDC 63850-0134

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 63850-0134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label (Pomalidomide Capsules 1mg 100capsules)

Pomalidomide 1 mg capsules label showing product name, strength, and dosage form. The label includes storage instructions, a birth defect warning, manufacturer Natco Pharma Limited, and packaging quantity of 100 capsules. Also visible are barcode, lot, and expiration placeholders.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 1mg 21capsules)

Label for Pomalidomide Capsules 1 mg by Natco Pharma Limited. The label includes storage instructions, a warning about potential human birth defects, a barcode, and mentions a package size of 21 capsules for oral use. It specifies the NDC 63850-0131-1 and advises pharmacists to dispense the medication guide.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 2mg 100capsules)

Pomalidomide 2 mg oral capsules label from Natco Pharma Limited. The label states each capsule contains 2 mg of Pomalidomide and includes storage instructions, a warning about potential human birth defects, and a note for pharmacists to dispense an enclosed Medication Guide. The package contains 100 capsules and is prescription only.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 2mg 21capsules)

Label for Pomalidomide 2 mg capsules by Natco Pharma Limited. The label includes dosage strength, storage instructions, a warning about potential birth defects, pharmacist dispensing instructions, and package quantity of 21 capsules. Also present are NDC, GTIN, lot number, and expiration date placeholders.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 3mg 100capsules)

Pomalidomide 3 mg capsules label showing the active ingredient strength and dosage form. The label includes storage instructions, a warning about potential birth defects, manufacturer Natco Pharma Limited, and package size of 100 capsules. It also features a barcode and National Drug Code (NDC) 63850-0133-2.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 3mg 21capsules)

Label for Pomalidomide Capsules 3 mg oral capsules by Natco Pharma Limited. The label includes storage instructions, a birth defect warning, pharmacist dispensing instructions, package count of 21 capsules, and the NDC 63850-0133-1. Manufacturer address and barcodes are also present.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 4mg 100capsules)

Pomalidomide 4 mg capsules label shows the active ingredient strength as 4 mg per capsule. The label includes storage instructions, manufacturer Natco Pharma Limited in India, a warning about potential human birth defects, and a quantity of 100 capsules. The label also has an NDC number 63850-0134-2 and a barcode.*

FDA Label Image

Bottle-label (Pomalidomide Capsules 4mg 21capsules)

Label for Pomalidomide capsules 4 mg manufactured by Natco Pharma Limited. The label includes storage instructions, a warning about potential birth defects, and states the package contains 21 capsules. It features an NDC number (63850-0134-1), barcode, and space for lot and expiration details.*

FDA Label Image

Figure-1 (Pomalidomide Capsules Figure 1)

A Kaplan-Meier survival curve comparing progression free survival between two groups labeled HD-DEX and POM-LD-DEX over a period of months. The vertical axis shows the proportion of subjects, and the horizontal axis shows progression free survival in months. A table below the graph presents the number of subjects at risk at different time points for each group.*

FDA Label Image

Figure-2 (Pomalidomide Capsules Figure 2)

A Kaplan-Meier survival curve comparing overall survival over months between two treatment groups, HD-DEX and POM-LD-DEX, with the y-axis representing the proportion of subjects and the x-axis representing time in months. The graph includes risk tables for subject counts at various time points.*

FDA Label Image

Structure (Pomalidomide Capsules Structure)

Chemical structure of pomalidomide, showing its molecular framework with an amino group and two distinct ring structures.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.